Insider Transactions Reported by 16 Insiders of Immuneering Corp

Symbol
IMRX on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Immuneering Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Benjamin J. Zeskind PRESIDENT AND CEO, Director, 10%+ Owner $9.93M +$85K +0.86% 01 Jul 2025
Peter Feinberg Director $9.06M +$202K +2.28% 03 Oct 2025
Cormorant Asset Management, LP 10%+ Owner $8.6M 01 Apr 2024
Brett Matthew Hall Chief Scientific Officer $534K +$34.6K +6.93% 15 Sep 2025
Thomas J. Schall Director $194K +$124K +178% 27 Jun 2025
Mallory Morales Chief Accounting Officer $176K +$1.92K +1.1% 01 Oct 2025
Leah R. Neufeld Chief People Officer $149K +$7.6K +5.38% 01 Oct 2025
Michael Bookman Chief Legal Officer, Secretary $33.3K +$6.97K +26.5% 01 Oct 2025
Biren Amin Cfo, Treasurer $23.8K 12 May 2022
DIANA HAUSMAN Director $19.9K +$19.9K 02 Jul 2025
Harold E. Brakewood Chief Business Officer $14.7K +$4.8K +48.7% 20 Jun 2025
Igor Matushansky Chief Medical Officer 21 Mar 2025
ANN E. BERMAN Director 13 Jun 2025
CARPENTER ROBERT J Director 13 Jun 2025
Scott Barrett Chief Medical Officer 15 Feb 2023
LAURIE KEATING Director 13 Jun 2025

Recent Insider Transactions by Companies or Individuals for Immuneering Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.